A citation-based method for searching scientific literature

Emily Y Chew, Walter T Ambrosius, Matthew D Davis, Ronald P Danis, Sapna Gangaputra, Craig M Greven, Larry Hubbard, Barbara A Esser, James F Lovato, Letitia H Perdue, David C Goff, William C Cushman, Henry N Ginsberg, Marshall B Elam, Saul Genuth, Hertzel C Gerstein, Ulrich Schubart, Lawrence J Fine. N Engl J Med 2010
Times Cited: 721







List of co-cited articles
1221 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.
A C Keech, P Mitchell, P A Summanen, J O'Day, T M E Davis, M S Moffitt, M-R Taskinen, R J Simes, D Tse, E Williamson,[...]. Lancet 2007
616
48

Global prevalence and major risk factors of diabetic retinopathy.
Joanne W Y Yau, Sophie L Rogers, Ryo Kawasaki, Ecosse L Lamoureux, Jonathan W Kowalski, Toke Bek, Shih-Jen Chen, Jacqueline M Dekker, Astrid Fletcher, Jakob Grauslund,[...]. Diabetes Care 2012
26



Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models.
Ying Chen, Yang Hu, Mingkai Lin, Alicia J Jenkins, Anthony C Keech, Robert Mott, Timothy J Lyons, Jian-xing Ma. Diabetes 2013
103
12

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.
A Keech, R J Simes, P Barter, J Best, R Scott, M R Taskinen, P Forder, A Pillai, T Davis, P Glasziou,[...]. Lancet 2005
11

Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.
C P Wilkinson, Frederick L Ferris, Ronald E Klein, Paul P Lee, Carl David Agardh, Matthew Davis, Diana Dills, Anselm Kampik, R Pararajasegaram, Juan T Verdaguer. Ophthalmology 2003
11

The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study.
Emily Y Chew, Matthew D Davis, Ronald P Danis, James F Lovato, Letitia H Perdue, Craig Greven, Saul Genuth, David C Goff, Lawrence A Leiter, Faramarz Ismail-Beigi,[...]. Ophthalmology 2014
135
10

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
10

Diabetic Retinopathy: A Position Statement by the American Diabetes Association.
Sharon D Solomon, Emily Chew, Elia J Duh, Lucia Sobrin, Jennifer K Sun, Brian L VanderBeek, Charles C Wykoff, Thomas W Gardner. Diabetes Care 2017
236
9

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.
Faramarz Ismail-Beigi, Timothy Craven, Mary Ann Banerji, Jan Basile, Jorge Calles, Robert M Cohen, Robert Cuddihy, William C Cushman, Saul Genuth, Richard H Grimm,[...]. Lancet 2010
795
9

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Michael J Elman, Lloyd Paul Aiello, Roy W Beck, Neil M Bressler, Susan B Bressler, Allison R Edwards, Frederick L Ferris, Scott M Friedman, Adam R Glassman, Kellee M Miller,[...]. Ophthalmology 2010
870
9

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.
I M Stratton, E M Kohner, S J Aldington, R C Turner, R R Holman, S E Manley, D R Matthews. Diabetologia 2001
564
9

Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.
David R Matthews, Irene M Stratton, Stephen J Aldington, Rury R Holman, Eva M Kohner. Arch Ophthalmol 2004
256
8

Effects of lipid-lowering agents on diabetic retinopathy: a Meta-analysis and systematic review.
Rui Shi, Lei Zhao, Feng Wang, Fen Liu, Zhuo Chen, Rong Li, Yang Liu, Rong Lin. Int J Ophthalmol 2018
17
47

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.
Paul Mitchell, Francesco Bandello, Ursula Schmidt-Erfurth, Gabriele E Lang, Pascale Massin, Reinier O Schlingemann, Florian Sutter, Christian Simader, Gabriela Burian, Ortrud Gerstner,[...]. Ophthalmology 2011
815
8

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
8

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
8

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
Quan Dong Nguyen, David M Brown, Dennis M Marcus, David S Boyer, Sunil Patel, Leonard Feiner, Andrea Gibson, Judy Sy, Amy Chen Rundle, J Jill Hopkins,[...]. Ophthalmology 2012
920
8

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
8

Diabetic retinopathy.
Ning Cheung, Paul Mitchell, Tien Yin Wong. Lancet 2010
8

Glucose control and vascular complications in veterans with type 2 diabetes.
William Duckworth, Carlos Abraira, Thomas Moritz, Domenic Reda, Nicholas Emanuele, Peter D Reaven, Franklin J Zieve, Jennifer Marks, Stephen N Davis, Rodney Hayward,[...]. N Engl J Med 2009
8

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata, Ayesha A Motala, Katherine Ogurtsova,[...]. Diabetes Res Clin Pract 2019
8

Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials.
Sophia Zoungas, Hisatomi Arima, Hertzel C Gerstein, Rury R Holman, Mark Woodward, Peter Reaven, Rodney A Hayward, Timothy Craven, Ruth L Coleman, John Chalmers. Lancet Diabetes Endocrinol 2017
175
7

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Jeffrey G Gross, Adam R Glassman, Lee M Jampol, Seidu Inusah, Lloyd Paul Aiello, Andrew N Antoszyk, Carl W Baker, Brian B Berger, Neil M Bressler, David Browning,[...]. JAMA 2015
332
7

Renal and retinal effects of enalapril and losartan in type 1 diabetes.
Michael Mauer, Bernard Zinman, Robert Gardiner, Samy Suissa, Alan Sinaiko, Trudy Strand, Keith Drummond, Sandra Donnelly, Paul Goodyer, Marie Claire Gubler,[...]. N Engl J Med 2009
486
7


Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
7

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.
John A Wells, Adam R Glassman, Allison R Ayala, Lee M Jampol, Neil M Bressler, Susan B Bressler, Alexander J Brucker, Frederick L Ferris, G Robert Hampton, Chirag Jhaveri,[...]. Ophthalmology 2016
402
7


Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.
Ryan Lee, Tien Y Wong, Charumathi Sabanayagam. Eye Vis (Lond) 2015
462
7

Intravitreal aflibercept for diabetic macular edema.
Jean-François Korobelnik, Diana V Do, Ursula Schmidt-Erfurth, David S Boyer, Frank G Holz, Jeffrey S Heier, Edoardo Midena, Peter K Kaiser, Hiroko Terasaki, Dennis M Marcus,[...]. Ophthalmology 2014
415
7

Diabetic retinopathy.
David A Antonetti, Ronald Klein, Thomas W Gardner. N Engl J Med 2012
887
7

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.
Nish Chaturvedi, Massimo Porta, Ronald Klein, Trevor Orchard, John Fuller, Hans Henrik Parving, Rudy Bilous, Anne Katrin Sjølie. Lancet 2008
293
7

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
John A Wells, Adam R Glassman, Allison R Ayala, Lee M Jampol, Lloyd Paul Aiello, Andrew N Antoszyk, Bambi Arnold-Bush, Carl W Baker, Neil M Bressler, David J Browning,[...]. N Engl J Med 2015
792
7

Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings.
Tien Y Wong, Jennifer Sun, Ryo Kawasaki, Paisan Ruamviboonsuk, Neeru Gupta, Van Charles Lansingh, Mauricio Maia, Wanjiku Mathenge, Sunil Moreker, Mahi M K Muqit,[...]. Ophthalmology 2018
137
7


10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
7

Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices.
Michael D Abràmoff, Philip T Lavin, Michele Birch, Nilay Shah, James C Folk. NPJ Digit Med 2018
243
6

Differential association of serum lipids with diabetic retinopathy and diabetic macular edema.
Rehab Benarous, Muhammad B Sasongko, Salmaan Qureshi, Eva Fenwick, Mohamed Dirani, Tien Y Wong, Ecosse L Lamoureux. Invest Ophthalmol Vis Sci 2011
68
8

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
L P Aiello, R L Avery, P G Arrigg, B A Keyt, H D Jampel, S T Shah, L R Pasquale, H Thieme, M A Iwamoto, J E Park. N Engl J Med 1994
6

Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus.
Elliott H Sohn, Hille W van Dijk, Chunhua Jiao, Pauline H B Kok, Woojin Jeong, Nazli Demirkaya, Allison Garmager, Ferdinand Wit, Murat Kucukevcilioglu, Mirjam E J van Velthoven,[...]. Proc Natl Acad Sci U S A 2016
225
6

Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis.
Bin Wang, Fang Wang, Yue Zhang, Shi-Hua Zhao, Wen-Juan Zhao, Sheng-Li Yan, Yan-Gang Wang. Lancet Diabetes Endocrinol 2015
59
10

Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis.
Seth R Flaxman, Rupert R A Bourne, Serge Resnikoff, Peter Ackland, Tasanee Braithwaite, Maria V Cicinelli, Aditi Das, Jost B Jonas, Jill Keeffe, John H Kempen,[...]. Lancet Glob Health 2017
831
6

Pathogenic role of diabetes-induced PPAR-α down-regulation in microvascular dysfunction.
Yang Hu, Ying Chen, Lexi Ding, Xuemin He, Yusuke Takahashi, Yang Gao, Wei Shen, Rui Cheng, Qian Chen, Xiaoping Qi,[...]. Proc Natl Acad Sci U S A 2013
76
7

Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
6






Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.